<DOC>
	<DOCNO>NCT00885092</DOCNO>
	<brief_summary>The purpose study clinically evaluate investigational multi-purpose disinfect solution ( MPDS ) compare commercial MPDS respect wettability silicone hydrogel contact lenses .</brief_summary>
	<brief_title>Single Site Study Wettability Contact Lenses With Investigational Multi-Purpose Disinfecting Solution vs. Marketed Multi-Purpose Solution</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>18 year age old . Must successfully wear assign study lens brand ( either ACUVUE® OASYS™ PureVision® contact lens ) least 710 day , minimum 8 hour day , prior Visit 1 ( screen ) . Vision correctable 20/30 ( Snellen ) good eye distance study lenses Visit 1 ( screen ) . Must discontinue contact lens wear least two consecutive day Visit 2 ( baseline ) . Other protocoldefined inclusion criterion may apply . Any medical condition ( systemic ophthalmic ) may , opinion investigator , preclude safe administration test article safe participation study . Known sensitivity intolerance protocolspecified contact lens solution , eye drop , product contain similar ingredient ( e.g. , generic product ) . Monocular vision ( one eye functional vision ) fit one contact lens . Use topical ocular overthecounter prescribe topical ocular medication , exception rewetting drop , within 7 day prior screen visit . Current history ocular infection , inflammation , disease , structural abnormality condition within last 6 month could affect study participation may preclude safe administration investigational lens care solution , opinion investigator . Any corneal surgery , cataract surgery , intraocular lens implant glaucoma filter surgery within last 12 month . Any slitlamp finding score 1 ( rat 3 4 limbal bulbar conjunctival injection ) screen baseline visit . Corneal stain area assessment ≥ 20 % corneal region either eye screen baseline visit . Corneal stain grade 2 ( macropunctate ) great corneal region either eye baseline visit . Participation investigational clinical study within 30 day baseline visit . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Contact lens</keyword>
	<keyword>Disinfecting solution</keyword>
</DOC>